CHICAGO--(BUSINESS WIRE)--ClearTrial (http://www.cleartrial.com), the leading provider of software for the planning, forecasting, and tracking of clinical project and financial performance, announced today that the company has been selected to serve as a conference chair for Cambridge Healthtech Institute's (CHI) Summit for Clinical Operations Executives (SCOPE) Conference. Andrew Grygiel, Vice President of Marketing and Product Management for ClearTrial, will open the conference's Clinical Trial Forecasting, Budgeting, and Project Management Track. Attended each year by more than 400 key biopharmaceutical and medical device executives, SCOPE features best practice case studies and interactive discussions relevant to clinical operations experts.
